Navigation Links
Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting
Date:4/16/2008

-060 treatment was well-tolerated with no clinically meaningful infusion reactions. The most frequently reported drug-related adverse events were fatigue and pyrexia considered to be mild to moderate in severity.

About Anti-CD30 Antibody Therapy

MDX-060 is a fully human antibody that targets CD30, a marker found on activated lymphocytes that is present on malignant cells of Hodgkin's disease (HD) as well as other CD30-expressing cancers. Medarex is currently conducting an ongoing Phase 2 proof-of-concept trial of MDX-060 in combination with gemcitabine for HD. Medarex is also developing MDX-1401, a second-generation non-fucosylated version of the MDX-060 parental antibody, that is enhanced for greater antibody-dependent cellular cytotoxicity and is being explored in a multi-dose, dose-escalation Phase 1 clinical trial for HD.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 40 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at http://www.medarex.com.

'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
10. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... The third edition of Infusion Nursing: ... by the Infusion Nurses Society (INS), includes Totect(®), ... Anthracyclines are a group of chemotherapy medications including ... used in the treatment of various types of ... According to the INS publication: "In September 2007, ...
(Date:12/14/2009)... thermoforming company, has completed the delivery of Brookfield Engineering’s Powder ... a plastic enclosure with a smaller footprint and more compact ... ... December 14, 2009 -- ThermoFab, a US-based thermoforming company, has ... helping Brookfield move from sheet metal to a plastic enclosure ...
(Date:12/11/2009)... have discovered a new explanation for differences in the severity ... a certain gene, the more serious the handicap. The genetic ... that it is the amount of copies of the GDI1 ... the American Journal of Human Genetics , and are ... connected to VIB, a life sciences research institute in Flanders, ...
(Date:12/11/2009)... Gwathmey, Inc., a pre-clinical contract research organization and ... cardiovascular disease announces a new CEO. ... Ph.D., has joined Gwathmey as Chief Executive Officer. ... experience working with small businesses and the federal ... managed multimillion dollar portfolios for the National Institutes ...
Breaking Biology Technology:Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2Amount of gene surplus determines severity of mental retardation in males 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2
... Associates, a San,Diego-based regulatory affairs and drug development ... diabetes and related metabolic diseases,during the months of ... and,Drug Administration officials Dr. Alexander Fleming and Dr. ... other guest speakers and panelists., Researchers and ...
... Pharmaceuticals,Inc. (Amex: ANX ) announced today that Eric ... of ImClone Systems Incorporated, will,join its Board of Directors. ... of its Board from six to seven directors., ... of Directors. He brings,tremendous knowledge and expertise within the ...
... energy from sunlight falling on only 9 percent ... the United States electricity needs if the energy ... Unfortunately, current-generation solar cell technologies are too expensive ... team of Northwestern University researchers has developed a ...
Other Biology Technology:The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics 2Eric K. Rowinsky Joins ADVENTRX Board of Directors 2Eric K. Rowinsky Joins ADVENTRX Board of Directors 3Eric K. Rowinsky Joins ADVENTRX Board of Directors 4Special coating greatly improves solar cell performance 2
(Date:12/11/2009)... species of wild apples that could be an ancestor ... and Central Asia. A new study comparing the diversity ... Georgia and Armenia with previously collected varieties originating in ... a core collection that will make M. orientalis ... , To identify and record the genetic diversity of ...
(Date:12/11/2009)... decades, Ivy Pike, an associate professor of anthropology at ... in rural northern Kenya to understand how violence shapes ... , The results of her and her colleagues, research," ... pastoralist communities of northern Kenya: A conceptual framework," is ... Science and Medicine , in collaboration with the British ...
(Date:12/11/2009)... profits have traditionally been limited by the ... seasons can be short. Thanks to researchers ... being introduced that offer growers the ability ... economic bonuses for both producers and consumers. ... blackberry called "primocane-fruiting", which bear fruit on ...
Breaking Biology News(10 mins):Understanding apples' ancestors 2UA-led study grapples with health effects of low-intensity warfare 2New management methods extend blackberry season 2Improved Screening for Jaundice Can Protect Newborns 58406 1Improved Screening for Jaundice Can Protect Newborns 58406 2New study resolves the mysterious origin of Merkel cells 58402 1Researchers believe hormone therapy should not be stopped prior to mammograms 58398 1Researchers believe hormone therapy should not be stopped prior to mammograms 58398 2
... Investigators at the Burnham Institute for Medical Research (Burnham) ... stem cells (hESCs) into neural progenitor cells that may ... Terskikh, Ph.D., and colleagues, outlines a method to create ... does not produce mutations in the cells and could ...
... help HIV hide from the immune system undermine the virus,s ... the April 13 issue of the Journal of Experimental ... , When HIV infects a cell, a complex of ... alert killer T cells by displaying bits of the virus ...
... rock face, a migrating cancer cell has to keep a tight ... moment to move ahead. Chan et al. reveal that the focal ... study will be published online April 13 ( www.jcb.org ) and ... Journal of Cell Biology . , Crawling cancer cells send ...
Other Biology News:Creating ideal neural cells for clinical use 2HIV pays a price for invisibility 2
... Biochain's plant total protein western ... rapidly screening tissue specific protein ... placenta total protein is included ... interblot control for comparison between ...
...
IHC detection kit for BrdU in cells and tissues...
Tissue culture grade....
Biology Products: